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SCIENTIFIC REPORT
Refractive change in thyroid eye disease (a neglected
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Background/aims: The literature on refractive change in
thyroid eye disease (TED) is limited. This study documents the
refractive change in patients with TED undergoing orbital
decompression. The authors propose possible mechanisms
for their acquired refractive error.
Methods: This is a retrospective observational case study of
five patients with progressive TED. Their detailed eye
examinations including refractive state preoperatively and
postoperatively are presented.
Results: An acquired hypermetropic shift with active TED
before orbital decompression of up to 3.75D spherical
equivalent refraction (SER) is reported in one patient. Post-
orbital decompression, an induced myopic shift of between
1.00–2.50D SER for all patients is observed, noted to range
from 1 day following surgery to up to 9 months, dependent
on the availability of data. Axial length increased in two
cases corresponding to postoperative myopic shift. Magnetic
resonance imaging findings of one patient demonstrate
flattening of the posterior pole as a cause of the acquired
preoperative hypermetropia.
Conclusions: TED has a significant effect on the refractive
state of patients. The proposed mechanism of acquired
hypermetropia relates to increased volume of orbital contents
with flattening of the posterior globe. This is reversed with
successful orbital decompression. Documentation of refrac-
tive error in all cases of progressive TED is recommended.
Progressive acquired hypermetropia may be suggestive of
TED activity.
T
hyroid eye disease (TED) is a frequent extrathyroidal
manifestation of hyperthyroidism, occurring in more
than 30% of patients with Graves’ disease.1 TED typically
presents as an inflammatory orbitopathy with symptoms of
ocular irritation, pain, diplopia, photophobia, and blurred
vision. The spectrum of clinical signs will depend on the
orbital subcompartment involved and can include proptosis,
lid oedema and retraction; conjunctival hyperaemia and
chemosis; increased extraocular muscle (EOM) bulk with
restricted eye movements; secondarily elevated intraocular
pressure; choroidal folds, optic nerve compression; corneal
tear film deficiencies and exposure keratopathy.2 These
symptoms and signs typically peak at approximately six to
24 months following the onset of TED, and have a significant
impact on visual function.3 4 We present a series of patients
diagnosed with Graves’ disease confirmed clinically and
serologically by their referring physician. All cases developed
TED and demonstrate refractive changes. The current
literature on refractive change in TED is limited. We report
an observed hypermetropic shift during progressive disease
and myopic shift following orbital decompression where no
other cause of acquired refractive error could be identified.
MATERIAL AND METHODS
This study refers to the positive clinical findings of five
patients referred for management with progressive TED. All
patients had been treated with carbimazole and systemic
steroids. Total thyroidectomy and radioactive iodine were
required for cases 2 and 5, respectively. All patients
ultimately required orbital decompression. Medical records
were studied with patient consent. Ethics approval was not
required for this study. Detailed ocular examination included
measurement of best corrected visual acuity (BCVA) using a
logMAR chart, subjective or automatic refraction, pupil
reactions, ocular movements, Hertel’s exophthalmometry
(HE), slit lamp examination including examination of the
tear film, and confrontation visual fields. Magnetic resonance
imaging (MRI), axial length, and corneal astigmatism
measured by keratometry and corneal topography were
assessed in individual patients.
RESULTS
Case 1
A 53 year old man was referred for active TED of over
7 months with progressive hypermetropia, proptosis, chronic
irritation, and temporal chemosis. Initial visual acuity (VA)
in the left eye was 6/5, without refractive error; VA right eye
was 6/36 because of previous trauma which precluded
refraction. Fundus examination showed posterior pole eleva-
tion, optic disc swelling, and choroidal folds in the left eye.
Visual field testing documented an altitudinal inferior field
defect in the left eye (Allergan Humphrey/Zeiss).
Preoperative proptosis by HE was 23 mm in the left eye.
His BCVA in the left eye deteriorated to 6/12 at 3 weeks
preoperatively with refraction +3.50/+0.50645 D˚; represent-
ing a hypermetropic shift of +3.75D SER over approximately
6 months. Primary indication for decompression was com-
pressive optic neuropathy. A left sided two wall orbital
decompression was performed without complication. HE
decreased by 3 mm postoperatively. A mild worsening of
restriction in upgaze was noted postoperatively. Complete VA
readings and refractive error during this management
episode are reported in table 1. Reduction in hypermetropia
was evident within a day of surgery, and 1 month post-
operatively his BCVA improved to 6/9 with a refraction of
+1.00/+0.50615 D˚ in the left eye. A 2.50D myopic shift in SER
was observed at 1 month.
Case 2
A 43 year old woman was referred following a 15 year history
of hyperthyroidism. TED was chronic and relatively inactive
with visual blurring, diplopia, and proptosis. Preoperative
proptosis by HE was 28 mm in the right eye. Preoperatively,
Abbreviations: BCVA, best corrected visual acuity; EOM, extraocular
muscle; HE, Hertel’s exophthalmometry; MRI, magnetic resonance
imaging; SER, spherical equivalent refraction; SOLs, space occupying
lesions; TED, thyroid eye disease
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BCVA in the right eye was 6/5 with a refraction of 0.00/
+0.506154 D˚. Indications for decompression were both
symptomatic relief and cosmesis. A right sided three wall
orbital decompression was performed without complication.
HE decreased by 6 mm postoperatively. A marked restriction
in upgaze resolved following surgery. Two weeks post-
operatively her BCVA was 6/6 with a refraction of 22.25/
+0.5690 D˚. A 2.25D SER myopic shift was observed 2 weeks
postoperatively (table 1).
Case 3
A 34 year old man was referred with rapidly progressive TED
over 2 months. TED was active with ocular irritation,
epiphora, diplopia and proptosis. Preoperative proptosis by
HE was 24 mm in the left eye. Preoperative BCVA in the left
eye was 6/6-1 with a refraction of 21.50/+0.506180 D˚. BCVA
in the right eye was 6/6 with a refraction of 25.50/
+3.256104 D˚. Indications for decompression were both
symptomatic relief and cosmesis. A left sided two wall orbital
decompression was performed without complication. HE
decreased by 3 mm postoperatively. Extraocular movements
were normal preoperatively and postoperatively. At
2.25 months post-decompression, BCVA was stable with a
refraction of 23.00/+1.00664 D˚ (table 1). The 1.50D myopic
shift in spherical refraction observed postoperatively was
found to correspond to an increase in axial length measured
with A-scan (Alcon Biophysic OcuScan Version 3.02). Axial
length increased by 0.39 mm from 24.21 mm preoperatively
to 24.60 mm postoperatively. There was no significant
change in preoperative and postoperative keratometry read-
ings. Corneal topography (Orb Scan II, Version 3.0, Orbtek
Inc) was also unchanged.
Case 4
A 58 year old woman was referred with rapidly progressive
active TED over 3 months with diplopia, periorbital chemosis,
and oedema. BCVA was 6/18 in the right eye with a refraction
of +1.25/+0.25660 D˚; and BCVA 6/9 in the left eye with a
refraction of +1.0/+0.256160 D˚, 1 month preoperatively.
Preoperative proptosis by HE was 23 mm in the right eye
and 22 mm in the left. Computed tomography confirmed
apical compression caused by markedly enlarged EOMs.
Primary indication for decompression was bilateral compres-
sive optic neuropathy. Bilateral two wall orbital decompres-
sions were performed without complication. HE decreased by
5 mm right eye and 4 mm left eye, postoperatively.
Extraocular movements were restricted in all directions
preoperatively with marked bilateral restriction in upgaze.
Eye movements improved postoperatively, with moderate
residual restriction in upgaze bilaterally. A 1.375D SER in the
right eye and 1.00D SER in the left myopic shift was noted
postoperatively (table 1). The myopic shift in spherical
refraction observed postoperatively was found to correspond
to an increase in axial length measured with IOL master (Carl
Ziess, 2004) in both eyes. Axial length increased by 0.47 mm
in the right eye from 21.72 mm to 22.19 mm. Axial length
increased by 0.42 mm in the left eyefrom 21.45 mm to
21.87 mm. There was no significant change in preoperatively
and postoperative keratometry readings.
Case 5
A 40 year old man was referred following a 6 year history of
hyperthyroidism with inactive TED with proptosis and mild
diplopia. Preoperative BCVA in the left eye was 6/6 with a
refraction of +1.5/+0.56180 D˚. Preoperative MRI demon-
strates orbital changes consistent with TED, including
enlarged EOMs and optic nerve. Flattening of the posterior
pole on sagittal view is noted indicated by the arrow (fig 1).
Indications for decompression were symptomatic relief and
compressive optic neuropathy. A left sided two wall orbital
decompression was performed without complication. At
1 month follow up, BCVA remained 6/6 with a refraction of
21.0/+0.56180 D˚. A myopic shift of 2.50D SER was observed
postoperatively (table 1). A repeat MRI has not been
performed.
Table 1 Progress best corrected visual acuity (BCVA), spherical and cylindrical refraction, spherical equivalent refraction
(SER), total change in SER, preoperative and postoperative Hertel’s exophthalmometry (HE), and change in axial length for
cases of progressive TED requiring orbital decompression













1 L 7.25 months preop 6/5 0.00 0.00 0.00
3.25 months preop 6/9 23+1.25 +0.50630˚ +1.50
3 months preop 6/9 +1.75 +0.50630˚ +2.00
1.5 months preop 6/9 +2.00 +0.50640˚ +2.25
3 weeks preop 6/12 +3.50 +0.50645˚ +3.75 +3.75 preop
1 month postop 6/9 +1.00 +0.50615˚ +1.25 22.50 postop 23 20 No data
2 R Preoperative 6/5 0.00 +0.506154˚ +0.25
2 weeks postop 6/6 22.25 +0.50690˚ 22.00 22.25 postop 28 22 No data
3 L Immediate preop 6/6 2121.50 +0.506180˚ 21.25
2.25 months postop 6/6 2223.00 +1.00664˚ 22.50 21.25 postop 24 21 +0.39
4 R 1 month preop 6/18 +1.25 +0.25660˚ +1.375
9 months postop 6/6 20.25 +0.50645˚ 0.00 21.375 postop 23 18 +0.47
L 1 month preop 6/9 +1.00 +0.256160˚ +1.125
9 months postop 6/6 20.25 +0.75685˚ +0.125 21.00 postop 22 18 +0.42
5 L 6 weeks preop 6/6 +1.50 +0.506180˚ +1.75
1 month postop 6/6 21.00 +0.506180˚ 20.75 22.50 postop No data No data No data
Figure 1 Median parasagittal magnetic resonance imaging scan
demonstrating flattening of the posterior pole in association with thyroid
eye disease (arrow).
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DISCUSSION
We have documented a dramatic acquired hypermetropia
during progressive TED with significant myopic shift of 1.00D
or more following orbital decompression in a series of five
patients. The acquired hypermetropia developed as an acute
event, within 6 months, sufficient to reduce VA without
correction. The myopic shift following orbital decompression
ranged from 1 day following surgery to up to 9 months
dependent on the availability of data.
The literature is replete with reports of refractive change in
association with other orbital pathologies. An acquired
hypermetropia has been documented in association with
choroidal folds of varying aetiologies and orbital space
occupying lesions (SOLs).5–9 Case 1 only demonstrated
choroidal folds as a mechanism of acquired hypermetropia;
The literature reports an acquired hypermetropia of up to
6.0D with large choroidal folds.7 Orbital SOLs associated with
refractive change include cavernous haemangioma and
primary sarcoma of the orbit.10–12 In one series, hypermetropic
shift was associated with intraconal tumours, and astigmatic
shift was associated with extraconal tumours.8
Although there is little reference to refractive change
associated with TED reported in the literature, there are three
papers that do report other important refractive change. The
first describes a large series of patients with Graves’
ophthalmopathy demonstrating greater ‘‘with the rule’’
corneal astigmatism, uninfluenced by orbital, strabismus, or
eyelid surgery. Soft tissue fibrosis of the superolateral orbit
was considered a possible responsible mechanism. Other
refractive changes are not described.13 The second describes a
steepening of the inferior cornea with flattening of the
superior cornea following inferior rectus recession. Further
information for the refractive change is not provided.14 The
third refers to progressive myopia in two cases of TED, but
does not detail astigmatic change. The authors consider
infiltration and damage to the ciliary body, related to TED, as
a possible mechanism for myopia.15
Our observations of an acquired hypermetropia during
active TED (case 1) and myopic shift post-decompression is
consistent with mechanisms involving the posterior pole. We
propose that a combination of enlarged EOMs, anterior
displacement of the globe, and orbital hypertension related to
elevated muscle and fat volumes in TED flatten the posterior
pole, which may produce choroidal folds. Multiple choroidal
folds were observed at the posterior pole before surgery for
case 1; however, for the other cases, choroidal folds did not
appear in association with the plausible acquired hyperme-
tropia in eyes subject to similar orbital buckling forces on the
posterior pole. MRI findings for case 4 demonstrate compres-
sion of the posterior globe during active disease.
Analogous to the effect of a diffuse SOL, we suggest that
these buckling forces exert a tangential effect on the posterior
pole, decreasing axial length during active disease to explain
the observed acquired hypermetropic shift of 3.75D SER. The
postoperative increase in axial length (cases 3 and 4), of
between 0.39 mm and 0.47 mm, without significant change
in keratometry, is consistent with a myopic shift of 1.50D
spherical refraction and measurably indicates the effective-
ness of orbital decompression.
Missing data are a well recognised limitation of any
retrospective clinical case series and this study is not exempt.
The relative frequency of refractive change for this series
approximates 5.7%. The authors suspect the frequency of
refractive change to be higher than that which we have been
able to document to date. While this is a small series of five
patients, we believe the refractive changes reported are
substantially significant in magnitude to account for varia-
tion caused by interphysician and intraphysician measure-
ment error which we were also unable to calculate. In
addition, refraction was either subjective or automatic, where
patients were not assessed at each measure by both methods,
possibly reducing the accuracy of our readings.
The recognition of a hypermetropic shift, particularly in
patients nearing presbyopic age and afterwards as a cause for
decreased near vision, is important to consider. Patients may
have limited proptosis, and require careful monitoring for
optic neuropathy and the need for decompression.
Recognition with careful refraction provides important
clinical information. We now monitor refraction preopera-
tively, on the day of surgery, and during routine follow up at
1 week and 6 weeks as part of our protocol.
Several factors produce significant and varied refractive
change in TED. Our findings of an acquired hypermetropia
during progressive disease, with reversal following successful
decompression share mechanisms in common with orbital
SOLs. Given the infrequency of orbital decompression, it is
hoped this paper will stimulate further prospective colla-
borative study.
ACKNOWLEDGEMENTS
The authors thank the following participating investigators: Dr Peter
Martin, Dr Ross Benger, Dr Gina Kourt, and Dr Vidushi Sharma of
Sydney Eye Hospital, Sydney, Australia; we also thank Dr Raman
Malhotra, Queen Victoria Hospital, East Grinstead, United Kingdom
for contributing to this study.
Authors’ affiliations
. . . . . . . . . . . . . . . . . . . . .
S Chandrasekaran, C Petsoglou, F A Billson, R Ghabrial, Sydney Eye
Hospital, Sydney, Australia
C Petsoglou, F A Billson, R Ghabrial, Save Sight Institute, Department of
Ophthalmology and Eye Health, University of Sydney, Australia
D Selva, Department of Ophthalmology and Visual Sciences, University
of Adelaide, Australia
Competing interests: none declared
Correspondence to: Dr R Ghabrial, Sydney Oculoplastic Surgery, Level
7, 229 Macquarie Street, Sydney, NSW 2000, Australia; rafg@
bigpond.com
Accepted for publication 1 November 2005
REFERENCES
1 Burch HB, Wartofsky L. Graves’ ophthalmopathy: current concepts regarding
pathogenesis and management. Endocr Rev 1993;14:747–93.
2 Asman P. Ophthalmological evaluation in thyroid-associated
ophthalmopathy. Acta Ophthalmol Scand 2003;81:437–48.
3 Rundle FF. Eye signs of Graves’ disease. In: Pitt-Rivers R, Trotter WR, eds. The
thyroid. Washington DC: Butterworths, 1964:171–97.
4 Park JJ, Sullivan TJ, Mortimer RH, et al. Assessing quality of life in Australian
patients with Graves’ ophthalmopathy. Br J Ophthalmol 2004;88:75–8.
5 Murdoch D, Merriman M. Acquired hypermetropia with choroidal folds. Clin
Experiment Ophthalmol 2002;30:292–4.
6 Dailey RA, Mills RP, Stimac GK, et al. The natural history and CT appearance
of acquired hypermetropia with choroidal folds. Ophthalmology
1986;93:336–42.
7 Kalina RE, Mills RP. Acquired hypermetropia with choroidal folds.
Ophthalmology 1980;87:44–50.
8 Friberg TR, Grove AS. Choroidal folds and refractive errors associated with
orbital tumors. An analysis. Arch Ophthalmol 1983;101:598–603.
9 Jacobsen DM. Intracranial hypertension and the syndrome of acquired
hypermetropia with choroidal folds. J Neuroophthalmol 1995;15:178–85.
10 Harris GJ, Jakobiec FA. Cavernous hemangioma of the orbit. J Neurosurg
1979;51:219–28.
11 D’Hermies F, Elmaleh C, Mourier K, et al. Cavernous hemangioma of the
orbit. J Fr Opthalmol 1993;16:195–8.
12 Johnson LN, Sexton FM, Goldberg SH. Poorly differentiated primary orbital
sarcoma (presumed malignant rhabdoid tumor). Radiologic and
histopathologic correlation. Arch Ophthalmol 1991;109:1275–8.
13 Mombaerts I, Vandelanotte, Koornneef L. Corneal astigmatism in Graves’
ophthalmopathy. Eye (advance online publication, 22 April 2005).
14 Kwitko S, Feldon S, McDonnell PJ. Corneal topographic changes following
strabismus surgery in Grave’s disease. Cornea 1992;11:36–40.
15 Huismans H. Conspicuous change of refraction in endocrine orbitopathy. Klin
Monatsbl Augenheilkd 1991;198:215–16.
Refractive change in thyroid eye disease 309
www.bjophthalmol.com
 on 28 August 2008 bjo.bmj.comDownloaded from 
